Sublingual administration of Lactobacillus paracasei KW3110 inhibits Th2-dependent allergic responses via upregulation of PD-L2 on dendritic cells

Clinical Immunology

Volumn 143, Issue 2, 2012, Pages 170-179

  Inamine, Ayako ^a   Sakurai, Daijyu ^a   Horiguchi, Shigetoshi ^a   Yonekura, Syuji ^a   Hanazawa, Toyoyuki ^a   Hosokawa, Hiroyuki ^a   Matuura Suzuki, Asaka ^a   Nakayama, Toshinori ^a   Okamoto, Yoshitaka ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Allergy; Dendritic cells; Sublingual administration; Vaccination

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERLEUKIN 13; INTERLEUKIN 5; KW 3110; L 92; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CERVICAL LYMPH NODE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; UPREGULATION;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTI-ALLERGIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNOGLOBULIN E; LACTOBACILLUS; MICE; MICE, INBRED BALB C; OVALBUMIN; PHAGOCYTOSIS; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; RECEPTORS, CCR7; TH2 CELLS; UP-REGULATION;

EID: 84859744910     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.01.008     Document Type: Article

References (27)

1. Bousquet J., van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001, 108:S147-S334.
2. Valovirta E., Myrseth S.E., Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr. Opin. Allergy Clin. Immunol. 2008, 8:1-9.
3. Norman P.S. Immunotherapy: 1999-2004. J. Allergy Clin. Immunol. 2004, 113:1013-1023.
4. Lockey R.F., Nicoara-Kasti G.L., Theodoropoulos D.S., Bukantz S.C. Systemic reactions and fatalities associated with allergen immunotherapy. Ann. Allergy Asthma Immunol. 2001, 87:47-55.
5. Prescott S.L., Bjorkstén B. Probiotics for the prevention or treatment of allergic diseases. J. Allergy Clin. Immunol. 2007, 120:255-262.
6. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 2004, 114:131-136.
7. Betsi G.I., Papadavid E., Falagas M.E. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am. J. Clin. Dermatol. 2008, 9(2):93-103.
8. Xiao J.Z., Kondo S., Yanagisawa N., Takahashi N., Odamaki T., Iwabuchi N., Miyaji K., Iwatsuki K., Togashi H., Enomoto K., Enomoto T. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin. Exp. Allergy 2006, 36:1425-1435.
9. Johannsen H., Prescott S.L. Practical prebiotics, probiotics and synbiotics for allergists: how useful are they?. Clin. Exp. Allergy 2009, 39:1801-1814.
10. Van Overtvelt L., Moussu H., Horiot S., Samson S., Lombardi V., Mascarell L., van de Moer A., Bourdet-Sicard R., Moingeon P. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010, 28:2986-2992.
11. Fujiwara D., Inoue S., Wakabayashi H., Fujii T. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int. Arch. Allergy Immunol. 2004, 135:205-215.
12. Ichikawa S., Fujii R., Fujiwara D., Komiyama Y., Kaisho T., Sakaguchi M., Konishi Y. MyD88 but not TLR2, 4 or 9 is essential for IL-12 induction by lactic acid bacteria. Biosci. Biotechnol. Biochem. 2007, 71:3026-3032.
13. Weiss G., Rasmussen S., Zeuthen L.H., Nielsen B.N., Jarmer H., Jespersen L., Frøkiaer H. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 2010, 131:268-281.
14. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., Nagai H. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol. Int. 2007, 56:293-301.
15. Scheicher C., Mehlig M., Zecher R., Reske K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 1992, 154:253-264.
16. Shida K., Kiyoshima-Shibata J., Nagaoka M., Watanabe K., Nanno M. Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J. Dairy Sci. 2006, 89:3306-3317.
17. Kimura M.Y., Hosokawa H., Yamashita M., Hasegawa A., Iwamura C., Watarai H., Taniguchi M., Takagi T., Ishii S., Nakayama T. Regulation of T helper type 2 cell differentiation by murine Schnurri-2. J. Exp. Med. 2005, 201:397-408.
18. Matsumoto K., Inoue H., Nakano T., Tsuda M., Yoshiura Y., Fukuyama S., Tsushima F., Hoshino T., Aizawa H., Akiba H., Pardoll D., Hara N., Yagita H., Azuma M., Nakanishi Y. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J. Immunol. 2004, 172:2530-2541.
19. Takamura K., Fukuyama S., Nagatake T., Kim D.Y., Kawamura A., Kawauchi H., Kiyono H. Regulatory role of lymphoid chemokine CCL19 and CCL21 in the control of allergic rhinitis. J. Immunol. 2007, 179:5897-5906.
20. Lambrecht B.N. Dendritic cells and the regulation of the allergic immune response. Allergy 2005, 60:271-282.
21. Song J.H., Kim J.I., Kwon H.J., Shim D.H., Parajuli N., Cuburu N., Czerkinsky C., Kweon M.N. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J. Immunol. 2009, 182:6851-6860.
22. Allam J.P., Niederhagen B., Bücheler M., Appel T., Betten H., Bieber T., Bergé S., Novak N. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006, 61:166-172.
23. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 2003, 3:867-878.
24. Latchman Y., Wood C.R., Chernova T., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-268.
25. Oflazoglu E., Swart D.A., Anders-Bartholo P., Jessup H.K., Norment A.M., Lawrence W.A., Brasel K., Tocker J.E., Horan T., Welcher A.A., Fitzpatrick D.R. Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo. Eur. J. Immunol. 2004, 34:3326-3336.
26. Yonekura S., Okamoto Y., Okawa T., Hisamitsu M., Chazono H., Kobayashi K., Sakurai D., Horiguchi S., Hanazawa T. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis. Allergy Asthma Proc. 2009, 30:397-405.
27. Moingeon P., Batard T., Fadel R., Frati F., Sieber J., Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006, 61:151-165.